Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2016, vol. 25, nr 1, January-February, p. 33–42

doi: 10.17219/acem/60645

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The Frequencies of Haplotypes of FTO Gene Variants and Their Association with the Distribution of Body Fat in Non-Obese Poles

Katarzyna Kolačkov1,A,B,C,D,F, Łukasz Łaczmański1,B,C,E,F, Felicja Lwow2,C,D,E,F, David Ramsey3,C,D,F, Aleksandra Zdrojowy-Wełna1,B,F, Małgorzata Tupikowska4,B,F, Grażyna Bednarek-Tupikowska1,A,B,C,D,E,F

1 Department and Clinic of Endocrinology, Diabetology and Isotope Therapy, Wroclaw Medical University, Poland

2 Department of Health Promotion, University School of Physical Education, Wrocław, Poland

3 Department of Computer Science and Management, Wrocław University of Technology, Poland

4 Department and Clinic of Dermatology, Venereology and Allergology, Wroclaw Medical University, Poland

Abstract

Background. The minor allele frequencies (MAFs) of the FTO gene vary substantially among different ethnic groups, and this variation may explain, to some degree, the differences between estimates of the effects of these alleles on body fat distribution indicators.
Objectives. The aim of this study was to investigate the prevalence of fat mass and obesity associated (FTO) gene variants characterizing the structure of FTO haplotypes in a large Polish population, and to examine the influence of FTO gene variants on body fat distribution among metabolically obese normal weight (MONW) individuals, i.e. those with a normal BMI and visceral obesity.
Material and Methods. A total of 854 non-obese individuals aged from 20 to 40 years, residing in three different regions in Poland, were studied. All the patients from this group were genotyped for four FTO gene variants (rs9939609, rs9930506, rs1421085 and rs1121980). Simultaneous identification of all single nucleotide polymorphisms (SNPs) was conducted using the minisequencing method with a pair of designed specific primers.
Results. Over 90% of the diplotypes contain only the two most common haplotypes, in three combinations of haplotype pairs: CTAT/CTAT comprised 26.9% in women and 30.9% in men; CTAT/TCGA comprised 45.0% in women and 44.4% in men; and TCGA/TCGA comprised 19.3% in woman and 14.8% in men. The analysis of the variance in body fat distribution parameters shows no statistically significant differences between the three common haplotype pairs in either men or women.
Conclusion. The young Polish population is characterized by two disparate haplotypes of common FTO gene variants: TCGA (a risk SNP haplotype), and CTAT (a protective haplotype). No significant differences were found between fat distribution indicators in relation to haplotypes in either women and men.

Key words

FTO, haplotypes, MONW, body fat distribution

References (27)

  1. Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jimenez F: The concept of normal weight obesity. Progr Cardiovasc Dis 2014, 56, 426–433.
  2. Hinney A, Vogel CIG, Hebebrand J: From monogenic to polygenic obesity: Recent advances. Eur Child Adoles Psy 2010, 19, 297–310.
  3. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI: A common variant in the FTO gene is associated w
  4. Jacobsson JA, Schiöth HB, Fredriksson R: The impact of intronic single nucleotide polymorphisms and ethnic diversity for studies on the obesity gene FTO. Obes Rev 2012, 13, 1096–1109.
  5. Peng S, Zhu Y, Xu F, Ren X, Li X, Lai M: FTO gene polymorphisms and obesity risk: a meta-analysis. BMC Med 2011, 9. DOI: 10.1186/1741-7015-9-71.
  6. An integrated map of genetic variationfrom 1,092 human genomes The 1000 Genomes Project Consortium. The 1000 Genomes Project Consortium Nature 2012, 491, 56–65.
  7. Integrating common and rare genetic variation in diverse human populations. The International HapMap 3 Consortium. Nature 2010, 467, 52–58.
  8. The International HapMap Consortium. The International HapMap Project. Nature 426, 789–796 (2003). [www. hapmap.org].
  9. Bednarek-Tupikowska G, Stachowska B, Miazgowski T, Krzyżanowska-Świniarska B, Katra B, Jaworski M, Kuliczkowska-Płaksej J, Jokiel-Rokita A, Tupikowska M, Bolanowski M, Jędrzejuk D, Milewicz A: Evaluation of the prevalence of metabolic obesity and normal weight among the Polish population. Endokrynol Pol 2012, 63, 447–455.
  10. Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995, 12, 921–927.
  11. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS, Yeo GS, McDonough MA, Cunliffe S, McNeill LA, Galvanovskis J, Rorsman P, Robins P, Prieur X, Coll AP, Ma M, Jovanovic Z, Farooqi IS, Sedgwick B, Barroso I, Lindahl T, Ponting CP, Ashcroft FM, O’Rahilly S, Schofield CJ: The obesity–associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007, 318, 1469–1472.
  12. Fawcett KA, Barroso I: The genetics of obesity: FTO leads the way. Trends Genet 2010, 26, 266–274.
  13. Gulati P, Yeo GS: The biology of FTO: from nucleic acid demethylase to amino acid sensor. Diabetologia 2013, 56, 2113–2121.
  14. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orrú M, Usala G, Dei M, Lai S, Maschio A, Busonero F, Mulas A, Ehret GB, Fink AA, Weder AB, Cooper RS, Galan P, Chakravarti A, Schlessinger D, Cao A, Lakatta E, Abecasis GR: Genome–Wide Association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genetics 2007, 3, 1200–1210.
  15. Luczynski W, Zalewski G, Bossowski A: The association of the FTO rs9939609 polymorphisms with obesity and metabolic risk factors for cardiovascular diseases in Polish children. J Physiol Pharmacol 2012, 63, 241–248.
  16. Tercjak-Rećko M, Łuczyński Ł, Bernatowicz P, Zalewski G, Rembińska M, Lachowska U, Rećko P, Suchoń P, Czaban M, Sokal J, Koplińska A, Pajer Z, Bogdanowicz K, Nikliński J, Bossowski A: Polymorphism rs9939609 of FTO gene is related to the body mass index in children from Podlaskie voievodship. Med Wieku Rozw 2012, 16, 53–60.
  17. Sitek A, Rosset I, Strapagiel D, Majewska M, Ostrowska-Nawarycz L, Żądzińska E: Association of FTO gene with obesity in Polish schoolchildren. Anthropol Rev 2014, 77, 33–44.
  18. Zhang J, Rowe WL, Clark AG, Buetow KH: Genomewide distribution of high-frequency, completely mismatching SNP haplotype pairs observed to be common across human populations. Am J Hum Genet 2003, 73, 1073–1081.
  19. Łuczyński W, Fendler W, Ramatowska A, Szypowska A, Szadkowska A, Młynarski W, Chumiecki M, Jarosz-Chobot P, Chrzanowska J, Noczyńska A, Brandt A, Myśliwiec M, Głowińska-Olszewska B, Bernatowicz P, Kowalczuk O, Bossowski A: Polymorphism of the FTO gene influences body weight in children with type 1 diabetes without severe obesity. Int J Endocrinol 2014. ID:630712, DOI: 10.1155/2014/630712.
  20. Pyrzak B, Wisniewska A, Majcher A, Tysarowski A, Demkow U: Relation of fat-mass and obesity-associated gene polymorphism to fat mass content and body mass index in obese children. Adv Exp Med Biol 2013, 756, 255–262.
  21. Kowalska I, Malecki MT, Straczkowski M, Skupien J, Karczewska-Kupczewska M, Nikolajuk A, Szopa M, Adamska A, Wawrusiewicz-Kurylonek N, Wołczynski S, Sieradzki J, Gorska M: The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes. Diabetes Metab 2009, 35, 328–331.
  22. Kowalska I, Adamska A, Malecki MT, Karczewska-Kupczewska M, Nikolajuk A, Szopa M, Gorska M, Straczkowski M: Impact of the FTO gene variation on fat oxidation and its potential influence on body weight in women with polycystic ovary syndrome. Clin Endocrinol 2012, 77, 120–125.
  23. Crowther NJ, Ferris W: The impact of insulin resistance, gender, genes, glucocorticoids and ethnicity on body fat distribution. JEMDSA 2010 15, 115–120.
  24. Livshits G, Malkin I, Moayyeri A, Spector TD and Hammond CJ: Association of FTO gene variants with body composition in UK twins. Ann Hum Genet 2012, 76, 333–341.
  25. Sonestedt E, Gullberg B, Ericson U, Wirfält E, Hedblad B, Orho-Melander M: Association between fat intake, physical activity and mortality depending on genetic variation in FTO. Int J Obes 2011, 35, 1041–1049.
  26. Andreasen CH, Stender-Petersen KL, Mogensen MS, Torekov SS, Wegner L, Andersen G, Nielsen AL, Albrechtsen A, Borch-Johnsen K, Rasmussen SS, Clausen JO, Sandbaek A, Lauritzen T, Hansen L, Jørgensen T, Pedersen O, Hansen T: Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 2008, 57, 95–101.
  27. Do R, Bailey SD, Desbiens K, Belisle A, Montpetit A, Bouchard C, Pérusse L, Vohl MC, Engert JC: Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes 2008, 57, 1147–1150.
© Wroclaw Medical University